Fritsch, K <br/><br/>
High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).  [electronic resource] 

 -  Leukemia  04 2017 
 - 846-852 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2016.334  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Central Nervous System Neoplasms--diagnosis<br/>Female<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Lymphoma--diagnosis<br/>Male<br/>Methotrexate--administration & dosage<br/>Neoplasm Staging<br/>Proportional Hazards Models<br/>Quality of Life<br/>Remission Induction<br/>Treatment Outcome<br/>Tumor Burden